Acadia Pharmaceuticals (ACAD) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Acadia Pharmaceuticals (ACAD) over the last 14 years, with Q4 2024 value amounting to $10.2 million.
- Acadia Pharmaceuticals' Accumulated Depreciation & Amortization rose 691.71% to $10.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $10.2 million, marking a year-over-year increase of 691.71%. This contributed to the annual value of $10.2 million for FY2024, which is 691.71% up from last year.
- Latest data reveals that Acadia Pharmaceuticals reported Accumulated Depreciation & Amortization of $10.2 million as of Q4 2024, which was up 691.71% from $9.6 million recorded in Q4 2023.
- In the past 5 years, Acadia Pharmaceuticals' Accumulated Depreciation & Amortization registered a high of $10.2 million during Q4 2024, and its lowest value of $3.9 million during Q4 2020.
- For the 5-year period, Acadia Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $7.6 million, with its median value being $8.1 million (2022).
- As far as peak fluctuations go, Acadia Pharmaceuticals' Accumulated Depreciation & Amortization crashed by 2595.65% in 2020, and later skyrocketed by 5663.63% in 2021.
- Acadia Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $3.9 million in 2020, then skyrocketed by 56.64% to $6.2 million in 2021, then skyrocketed by 30.93% to $8.1 million in 2022, then grew by 18.02% to $9.6 million in 2023, then grew by 6.92% to $10.2 million in 2024.
- Its Accumulated Depreciation & Amortization stands at $10.2 million for Q4 2024, versus $9.6 million for Q4 2023 and $8.1 million for Q4 2022.